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On December 2, 2014, the Nutrition Risk SRP, participants from the JSC, HQ, the NSBRI, and 
NRESS participated in a WebEx/teleconference.  The purpose of the call (as stated in the 
Statement of Task) was to allow the SRP members to: 
 
1. Receive an update by the Human Research Program (HRP) Chief Scientist or Deputy 
Chief Scientist on the status of NASA’s current and future exploration plans and the 
impact these will have on the HRP. 
2. Receive an update on any changes within the HRP since the 2013 SRP meeting. 
3. Receive an update by the Element or Project Scientist(s) on progress since the 2013 SRP 
meeting. 
4. Participate in a discussion with the HRP Chief Scientist, Deputy Chief Scientist, and the 
Element regarding possible topics to be addressed at the next SRP meeting. 
 
Based on the presentations and the discussion during the WebEx/teleconference, the SRP would 
like to relay the following information to Dr. Shelhamer, the HRP Chief Scientist. 
 
1. The SRP thought the teleconference was very informative and all SRP members were 
impressed with the quality of research that is being conducted. 
 
2. The SRP thinks the HRP and more specifically the nutrition portfolio (the Risk of 
Inadequate Nutrition) has continued to explore important areas of concern regarding 
spaceflight originally garnered from near Earth orbit with the intent to expand into deep 
spaceflight in the future. 
 
3. The principal issues brought up during the status review were the exploration of visual 
issues related presumably to intracranial hypertension which has been associated with 
folic acid single nucleotide polymorphisms (SNP's), the anorexia and related body mass 
loss with prolonged spaceflight, effects of spaceflight on vitamin D metabolism and 
supplementation, optimal protein, calcium, and sodium intakes, and anabolic and 
catabolic effects of spaceflight on bone metabolism.  The nutrition portfolio led by Dr. 
Scott Smith has diligently investigated the most pressing issues above in a comprehensive 
manner.  Below are some suggestions that the SRP thinks might be of some value to 
these important endeavors: 
 
a. There is continued support from the SRP for examining the underlying causes of 
the “flight-induced” vision changes and possible underlying nutritional 
mechanisms.  The SRP also suggests examining lutein status non-invasively.  
Lutein status can be tested non-invasively using Raman spectroscopy.  Lutein is 
the primary antioxidant in the macula and in the brain and it appears to be 
concentrated there by specific transport proteins.  For example, while lutein is 
only 28% of carotenoids in the blood, it comprises 58% of carotenoids in the 
brain.  The SRP thinks this work may complement the one-carbon metabolism 
study.  It may be that the two are related with the one-carbon metabolism 
difference setting up a susceptibility to oxidation and the lutein reflecting the 
oxidative damage.  In any case, lutein supplementation with foods is simple as 
spinach contains 6 mg per 100 g. 





b. The potential for personalized countermeasures targeting the increased risk for 
visual disturbance associated with the GG polymorphism and altered one-carbon 
metabolism is particularly intriguing. 
 
c. The SRP thinks that work on gut microbiome changes and implications for 
nutritional status during spaceflight would represent an important new 
interdisciplinary area.  Research on the microbiome is expanding with work 
showing an important influence of probiotics and prebiotic fibers.  This should be 
a major area of interdisciplinary research. 
 
d. The Integrated Nutrition Project on the use of functional foods to mitigate bone 
loss on the International Space Station (ISS) remains of considerable interest to 
the SRP.  Hopefully the project will achieve the same objectives through the 
operational effort that has recently been prescribed.  The cytokine findings that 
were presented during the status review are consistent with ongoing inflammation 
in spaceflight.  Stress, sleep disturbance, and behavioral issues may well be 
contributing factors.  Anti-inflammatory nutritional countermeasures may prove 
efficacious. 
 
e. The SRP thinks the loss of weight as fat vs. lean should be further examined 
based on baseline lean body mass and protein intake.  It may be that there is a 
relationship there.  The idea that carbohydrate and protein are both fine and that 
calories is all that matters is not supported by the scientific literature (Dr. 
Hellerstein has developed methods for studying these issues using stable 
isotopes). 
 
f. The SRP thinks further assessment of protein requirements and the pattern of 
diurnal protein intake still warrant further study with respect to spaceflight given 
the inflammatory burden and well described chronic low energy intake. 
 
